| Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society. | |
| | |
MedLine Citation:
|
PMID: 9164696 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Published medical evidence pertaining to the management of aneurysmal subarachnoid hemorrhage (SAH) was critically reviewed in order to prepare practice guidelines for this condition. SAH should be considered as a possible cause of all sudden and/or unusual headaches, and every attempt should be made to recognize mild SAHs, as they are still frequently misdiagnosed. The first test for SAH is computed tomography (CT), followed by lumbar puncture when the CT is negative for intracranial bleeding (the case in only several per cent of patients within 24 hours of aneurysm bleeding). Urgent cerebral angiography is necessary to detect the underlying cerebral aneurysm. The advantage of rapid diagnosis of SAH followed by early aneurysm repair is minimizing the risk of catastrophic aneurysm rebleeding. Early surgery for aneurysm repair is often possible and is recommended, unless the aneurysm location or size renders it technically difficult to expose in clot-laden subarachnoid cisterns beneath an acutely swollen brain. Aneurysm ablation is optimally accomplished with open microsurgery and clipping of the aneurysm neck, although other options include proximal parent artery occlusion, "trapping" of the aneurysmal segment of the artery, and embolization of thrombogenic materials (e.g., platinum "microcoils") directly into the aneurysm dome using endovascular techniques. Neurological outcome following SAH is also optimized through the prevention of secondary SAH complications, and further management specific for ruptured cerebral aneurysms can include anticonvulsants, neuroprotectants, and various agents and techniques to prevent or reverse delayed-onset cerebral vasospasm. All patients with aneurysmal SAH should be treated with the calcium antagonist nimodipine, and in certain circumstances patients should receive anticonvulsants. Induced arterial hypertension, hypervolemia and in some instances percutaneous balloon angioplasty are recommended to reverse vasospasm causing symptomatic cerebral ischemia prior to cerebral infarction. |
| | |
Authors:
|
J M Findlay |
Related Documents
:
|
19747046 - Intraaneurysmal balloon assistance for navigation across a wide-necked aneurysm. 20121386 - Iatrogenic cortical aneurysm post-craniotomy. 18948876 - Surgical treatment of celiac artery aneurysm associated with median arcuate ligament. 9254076 - Giant fusiform intracranial aneurysms: review of 120 patients treated surgically from 1... 6470976 - Influence of route of hepatic administration on drug availability. 8691516 - Complementary distal arteriovenous fistula and deep vein interposition: a five-year exp... |
Publication Detail:
|
Type: Guideline; Journal Article; Practice Guideline |
Journal Detail:
|
Title: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques Volume: 24 ISSN: 0317-1671 ISO Abbreviation: Can J Neurol Sci Publication Date: 1997 May |
Date Detail:
|
Created Date: 1997-07-17 Completed Date: 1997-07-17 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0415227 Medline TA: Can J Neurol Sci Country: CANADA |
Other Details:
|
Languages: eng Pagination: 161-70 Citation Subset: IM |
Affiliation:
|
Division of Neurosurgery, University of Alberta, Edmonton, Canada. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Intracranial Aneurysm / therapy* Subarachnoid Hemorrhage / therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lhermitte-Duclos disease: literature review and novel treatment strategy.
Next Document: CYP2D6-related oxidation polymorphism in a Canadian Inuit population.